Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07204756 · ClinicalTrials.gov registry record · NA

HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

A NA study of Hypertension and Postpartum, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT07204756 is a NA study of Hypertension and Postpartum that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 400 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07204756, a NA study of Hypertension and Postpartum, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

Interventions

  • DIAGNOSTIC_TEST 2-Week Home Monitoring
  • DIAGNOSTIC_TEST 6-Week Home Monitoring

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2026-01-07
Est. Completion 2028-01-31
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07204756

The ClinicalTrials.gov registry entry for NCT07204756 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (89% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which 2-Week Home Monitoring is the first listed.

NCT07204756 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07204756 about?

NCT07204756 is a clinical study titled "HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring". Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. Th...

What is the current status of trial NCT07204756?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2026-01-07. Estimated completion is 2028-01-31.

What conditions does trial NCT07204756 study?

This clinical trial studies the following conditions: Hypertension, Postpartum, Hypertensive Disorder of Pregnancy.

What interventions are being tested in trial NCT07204756?

The interventions under investigation include: 2-Week Home Monitoring (DIAGNOSTIC_TEST), 6-Week Home Monitoring (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07204756?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07204756 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.